IONIS PHARMACEUTICALS INC
Q2 2024 13F Holders
CUSIP
462222AF7
Type
Debt
Class
NOTE 1.750% 6/1
Num filings
39
Total reported value, excl. options
$489 M
Compare 2024 Q2 to
2025 Q1
2024 Q4
2024 Q3
Manager
Report Date
Value ($000)
Principal
Option Type